Sort
40,608 grants matching “prostate cancer”
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection
$680,042Alexander R. Ivanov · Northeastern University · R01 · FY2021 · CA
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression
$680,013Edward Giovannucci · Harvard School Of Public Health · R01 · FY2009 · CA
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
$679,977Marcia R Cruz Correa · University Of Puerto Rico Med Sciences · U54 · FY2018 · CA
Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer
$679,964Anant Madabhushi · Emory University · R01 · FY2022 · CA
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
$679,945B. R. Simon Rosser · University Of Minnesota · R01 · FY2022 · CA
EFFECT OF DIABETES AND OBESITY OF DISPARITIES IN PROSTATE CANCER OUTCOMES
$679,936Washington University, The · · FY2014 · Department of the Army
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy
$679,793Nagavarakishore Pillarsetty · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
ASSESSING EPHA2 AND EPHRIN-A AS NOVEL DIAGNOSTIC AND PROGNOSTIC BIOMARKERS OF PROSTATE CANCER
$679,747Case Western Reserve University · · FY2014 · Department of the Army
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:
$679,692Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study
$679,627Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2008 · CA
BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs
$679,564Daniel W Chan · Johns Hopkins University · U2C · FY2023 · CA
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
$679,536Corinne E. Joshu · Johns Hopkins University · R01 · FY2020 · CA
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$679,508Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry
$679,495Mia Hashibe · University Of Utah · R01 · FY2022 · CA
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
$679,482Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
A MODEL FOR UNDERSTANDING THE GENETIC BASIS FOR DISPARITY IN PROSTATE CANCER RISK
$679,399University Of Wisconsin System · · FY2015 · Department of the Army
Addressing the Biology of Health Disparities by Targeting Geographical Ancestry-driven Variants of Immunity
$679,079Kevin Sean Kimbro · North Carolina Central University · R01 · FY2022 · MD
Career Development in Pediatric and Medical Oncology
$678,791Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2019 · CA
Prostate Cancer Immunotherapy
$678,709Rockefeller University · R01 · FY2004 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING
$678,703John Kurhanewicz · University Of California, San Francisco · R01 · FY2018 · CA
Risk prediction methods
$678,702Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females
$678,675Tony Yuen · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Center for Applied Preclinical Research (CAPR)
$678,504Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
$678,469William Douglas Figg · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Clinical Pharmacogenetics
$678,469William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA